{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:52:40Z","timestamp":1791550360032,"version":"4.3.4"},"reference-count":123,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":186,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ghadvances.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastro Hep Advances"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.gastha.2026.101053","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T06:55:00Z","timestamp":1783666500000},"page":"101053","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cell Therapy in Advanced Cirrhosis: From Preclinical Evidence to Clinical Application"],"prefix":"10.1016","volume":"5","author":[{"given":"Kayleigh L.","family":"Thirlwell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Llewellyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford A.","family":"Brass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Campana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.gastha.2026.101053_bib1","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.gastha.2026.101053_bib2","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41575-021-00520-7","article-title":"Cirrhosis-associated immune dysfunction","volume":"19","author":"Albillos","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.gastha.2026.101053_bib3","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/s41575-025-01107-2","article-title":"Interaction of inflammation and portal hypertension in cirrhosis progression","volume":"22","author":"Costa","year":"2025","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.gastha.2026.101053_bib4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13287-023-03370-z","article-title":"Cell therapy in end-stage liver disease: replace and remodel","volume":"14","author":"Hu","year":"2023","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"10.1016\/j.gastha.2026.101053_bib5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jhep.2020.09.014","article-title":"Cell therapy for advanced liver diseases: repair or rebuild","volume":"74","author":"Dwyer","year":"2021","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.gastha.2026.101053_bib6","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/s41580-021-00373-7","article-title":"Liver regeneration and inflammation: from fundamental science to clinical applications","volume":"22","author":"Campana","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"10.1016\/j.gastha.2026.101053_bib7","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/stem.3154","article-title":"Advances in generating liver cells from pluripotent stem cells as a tool for modeling liver diseases","volume":"38","author":"Maepa","year":"2020","journal-title":"Stem Cells"},{"issue":"7","key":"10.1016\/j.gastha.2026.101053_bib8","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1136\/gutjnl-2024-333885","article-title":"Bioprinting functional hepatocyte organoids derived from human chemically induced pluripotent stem cells to treat liver failure","volume":"74","author":"Li","year":"2025","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.gastha.2026.101053_bib9","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1073\/pnas.1524510113","article-title":"Deterministically patterned biomimetic human iPSC-derived hepatic model via rapid 3D bioprinting","volume":"113","author":"Ma","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.gastha.2026.101053_bib10","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/ab4a30","article-title":"3D bioprinting of liver spheroids derived from human induced pluripotent stem cells sustain liver function and viability in vitro","volume":"12","author":"Goulart","year":"2019","journal-title":"Biofabrication"},{"issue":"6","key":"10.1016\/j.gastha.2026.101053_bib11","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1002\/hep.24315","article-title":"Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function","volume":"53","author":"Thomas","year":"2011","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.gastha.2026.101053_bib12","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.jcyt.2015.07.016","article-title":"Phenotypic and functional characterization of macrophages with therapeutic potential generated from human cirrhotic monocytes in a cohort study","volume":"17","author":"Moore","year":"2015","journal-title":"Cytotherapy"},{"issue":"3","key":"10.1016\/j.gastha.2026.101053_bib13","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/cam4.1998","article-title":"Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases-meta-analytic assessment","volume":"8","author":"Tarao","year":"2019","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.gastha.2026.101053_bib14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J Hepatol"},{"issue":"20","key":"10.1016\/j.gastha.2026.101053_bib15","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.gastha.2026.101053_bib16","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.3390\/cancers12061663","article-title":"Molecular bases of drug resistance in hepatocellular carcinoma","volume":"12","author":"Marin","year":"2020","journal-title":"Cancers"},{"issue":"6894","key":"10.1016\/j.gastha.2026.101053_bib17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature00858","article-title":"Release of chromatin protein HMGB1 by necrotic cells triggers inflammation","volume":"418","author":"Scaffidi","year":"2002","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.gastha.2026.101053_bib18","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1084\/jem.20111739","article-title":"HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4","volume":"209","author":"Schiraldi","year":"2012","journal-title":"J Exp Med"},{"issue":"8","key":"10.1016\/j.gastha.2026.101053_bib19","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1113\/JP281061","article-title":"Hepatic stellate cells in physiology and pathology","volume":"600","author":"Kamm","year":"2022","journal-title":"J Physiol"},{"issue":"1","key":"10.1016\/j.gastha.2026.101053_bib20","doi-asserted-by":"crossref","first-page":"4392","DOI":"10.1038\/s41598-020-60709-9","article-title":"Hypoxia sensing by hepatic stellate cells leads to VEGF-dependent angiogenesis and may contribute to accelerated liver regeneration","volume":"10","author":"Dirscherl","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.gastha.2026.101053_bib21","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hep.22950","article-title":"Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis","volume":"50","author":"Karlmark","year":"2009","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.gastha.2026.101053_bib22","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/gutjnl-2011-301494","article-title":"Hedgehog signalling regulates liver sinusoidal endothelial cell capillarisation","volume":"62","author":"Xie","year":"2013","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.gastha.2026.101053_bib23","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/gutjnl-2015-311224","article-title":"Gut microbial translocation corrupts myeloid cell function to control bacterial infection during liver cirrhosis","volume":"66","author":"Hackstein","year":"2017","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.gastha.2026.101053_bib24","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jacc.2009.12.075","article-title":"Cirrhotic cardiomyopathy","volume":"56","author":"Zardi","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.gastha.2026.101053_bib25","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.ejim.2014.09.004","article-title":"Clinical implications of the hyperdynamic syndrome in cirrhosis","volume":"25","author":"Licata","year":"2014","journal-title":"Eur J Intern Med"},{"issue":"5","key":"10.1016\/j.gastha.2026.101053_bib26","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41575-025-01050-2","article-title":"Cell therapy for liver disorders: past, present and future","volume":"22","author":"Ortu\u00f1o-Costela","year":"2025","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.gastha.2026.101053_bib27","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/stcltm\/szad084","article-title":"Human hepatocyte transplantation: three decades of clinical experience and future perspective","volume":"13","author":"Nulty","year":"2024","journal-title":"Stem Cells Transl Med"},{"issue":"4","key":"10.1016\/j.gastha.2026.101053_bib28","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1053\/he.2000.5636","article-title":"Hepatocyte transplantation in rats with decompensated cirrhosis","volume":"31","author":"Kobayashi","year":"2000","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.gastha.2026.101053_bib29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/096368979300200109","article-title":"Hepatocyte transplantation in man","volume":"2","author":"Mito","year":"1993","journal-title":"Cell Transplant"},{"issue":"7","key":"10.1016\/j.gastha.2026.101053_bib30","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.3727\/096368916X691286","article-title":"Instant blood-mediated inflammatory reaction in hepatocyte transplantation: current status and future perspectives","volume":"25","author":"Lee","year":"2016","journal-title":"Cell Transplant"},{"issue":"1","key":"10.1016\/j.gastha.2026.101053_bib31","doi-asserted-by":"crossref","first-page":"14.12.1","DOI":"10.1002\/0471140856.tx1412s62","article-title":"The history and use of human hepatocytes for the treatment of liver diseases: the first 100 patients","volume":"62","author":"Hansel","year":"2014","journal-title":"Curr Protoc Toxicol"},{"issue":"10","key":"10.1016\/j.gastha.2026.101053_bib32","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.3727\/096368913X669743","article-title":"Neonatal livers: a source for the isolation of good-performing hepatocytes for cell transplantation","volume":"23","author":"Tolosa","year":"2014","journal-title":"Cell Transplant"},{"issue":"8","key":"10.1016\/j.gastha.2026.101053_bib33","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.3727\/096368914X682422","article-title":"Phases I-II matched case-control study of human fetal liver cell transplantation for treatment of chronic liver disease","volume":"24","author":"Pietrosi","year":"2015","journal-title":"Cell Transplant"},{"issue":"5","key":"10.1016\/j.gastha.2026.101053_bib34","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/cr.2017.47","article-title":"Reversible transition between hepatocytes","volume":"27","author":"Wu","year":"2017","journal-title":"Cell Res"},{"issue":"1","key":"10.1016\/j.gastha.2026.101053_bib35","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41421-025-00831-y","article-title":"Treatment of liver cirrhosis using hepatocyte-derived liver progenitor-like cells: a prospective, open-label, single-arm, safety trial","volume":"11","author":"He","year":"2025","journal-title":"Cell Discov"},{"issue":"1","key":"10.1016\/j.gastha.2026.101053_bib36","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/hep.27084","article-title":"Clonal tracing of Sox9+ liver progenitors in mouse oval cell injury","volume":"60","author":"Tarlow","year":"2014","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.gastha.2026.101053_bib37","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/ncb3203","article-title":"Hepatic progenitor cells of biliary origin with liver repopulation capacity","volume":"17","author":"Lu","year":"2015","journal-title":"Nat Cell Biol"},{"issue":"1\u20132","key":"10.1016\/j.gastha.2026.101053_bib38","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.cell.2014.11.050","article-title":"Long-term culture of genome-stable bipotent stem cells from adult human liver","volume":"160","author":"Huch","year":"2015","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.gastha.2026.101053_bib39","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.stem.2022.02.006","article-title":"Human biliary epithelial cells from discarded donor livers rescue bile duct structure and function in a mouse model of biliary disease","volume":"29","author":"Hallett","year":"2022","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.gastha.2026.101053_bib40","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12876-014-0204-z","article-title":"Transplantation of human fetal biliary tree stem\/progenitor cells into two patients with advanced liver cirrhosis","volume":"14","author":"Cardinale","year":"2014","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"10.1016\/j.gastha.2026.101053_bib41","doi-asserted-by":"crossref","first-page":"36","DOI":"10.7150\/ijms.21666","article-title":"Ethical and safety issues of stem cell-based therapy","volume":"15","author":"Volarevic","year":"2018","journal-title":"Int J Med Sci"},{"issue":"4","key":"10.1016\/j.gastha.2026.101053_bib42","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/hep.24790","article-title":"Rapid generation of mature hepatocyte-like cells from human induced pluripotent stem cells by an efficient three-step protocol","volume":"55","author":"Chen","year":"2012","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.gastha.2026.101053_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117689","article-title":"DMSO efficiently down regulates pluripotency genes in human embryonic stem cells during definitive endoderm derivation and increases the proficiency of hepatic differentiation","volume":"10","author":"Czysz","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.gastha.2026.101053_bib44","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1038\/s41467-020-15337-2","article-title":"Stem cell-derived polarized hepatocytes","volume":"11","author":"Dao Thi","year":"2020","journal-title":"Nat Commun"},{"issue":"8065","key":"10.1016\/j.gastha.2026.101053_bib45","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/s41586-025-08850-1","article-title":"Multi-zonal liver organoids from human pluripotent stem cells","volume":"641","author":"Reza","year":"2025","journal-title":"Nature"},{"issue":"757","key":"10.1016\/j.gastha.2026.101053_bib46","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg0338","article-title":"Human iPSC-liver organoid transplantation reduces fibrosis through immunomodulation","volume":"16","author":"Tadokoro","year":"2024","journal-title":"Sci Transl Med"},{"issue":"4","key":"10.1016\/j.gastha.2026.101053_bib47","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.stem.2024.02.005","article-title":"Preclinical efficacy and safety of encapsulated proliferating human hepatocyte organoids in treating liver failure","volume":"31","author":"Yuan","year":"2024","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.gastha.2026.101053_bib48","doi-asserted-by":"crossref","DOI":"10.1093\/rb\/rbaf103","article-title":"Tissue-engineered liver using 3D-printed silk fibroin scaffolds loaded with stem cells for the treatment of acute liver injury","volume":"12","author":"Shi","year":"2025","journal-title":"Regen Biomater"},{"issue":"14","key":"10.1016\/j.gastha.2026.101053_bib49","doi-asserted-by":"crossref","first-page":"11592","DOI":"10.3390\/ijms241411592","article-title":"Pluripotent stem cell-derived hepatocyte-like cells: induction methods and applications","volume":"24","author":"Luo","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.gastha.2026.101053_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115675","article-title":"Bile acid-FXR signaling facilitates the long-term maintenance of hepatic characteristics in human iPSC-derived organoids","volume":"44","author":"Shimizu","year":"2025","journal-title":"Cell Rep"},{"issue":"21","key":"10.1016\/j.gastha.2026.101053_bib51","doi-asserted-by":"crossref","first-page":"8419","DOI":"10.1039\/D4MA00373J","article-title":"Hepatocyte-like cells and liver organoids: the application of iPSCs and their derivants for treating liver diseases","volume":"5","author":"Ju","year":"2024","journal-title":"Mater Adv"},{"issue":"1","key":"10.1016\/j.gastha.2026.101053_bib52","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jhep.2024.12.039","article-title":"Host hepatocyte senescence determines the success of hepatocyte transplantation in a mouse model of liver injury","volume":"83","author":"Gadd","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.gastha.2026.101053_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1480226","article-title":"Chemical approaches targeting the hurdles of hepatocyte transplantation: mechanisms, applications, and advances","volume":"12","author":"Shi","year":"2024","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"10.1016\/j.gastha.2026.101053_bib54","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13287-024-04127-y","article-title":"Mesenchymal stem cell therapy as a game-changer in liver diseases: review of current clinical trials","volume":"16","author":"Huang","year":"2025","journal-title":"Stem Cell Res Ther"},{"issue":"8","key":"10.1016\/j.gastha.2026.101053_bib55","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2536314123","article-title":"Regulatory T cells safeguard liver health during metabolic-associated steatohepatitis","volume":"123","author":"Hanna","year":"2026","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7814","key":"10.1016\/j.gastha.2026.101053_bib56","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41586-020-2403-9","article-title":"Senolytic CAR T cells reverse senescence-associated pathologies","volume":"583","author":"Amor","year":"2020","journal-title":"Nature"},{"issue":"833","key":"10.1016\/j.gastha.2026.101053_bib57","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adx0368","article-title":"Anti-FAP CAR T cells produced in vivo reduce fibrosis and restore liver homeostasis in metabolic dysfunction\u2013associated steatohepatitis","volume":"18","author":"Yashaswini","year":"2026","journal-title":"Sci Transl Med"},{"issue":"3","key":"10.1016\/j.gastha.2026.101053_bib58","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/s41591-024-03406-8","article-title":"Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trial","volume":"31","author":"Brennan","year":"2025","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.gastha.2026.101053_bib59","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/s41591-019-0599-8","article-title":"Safety profile of autologous macrophage therapy for liver cirrhosis","volume":"25","author":"Moroni","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.gastha.2026.101053_bib60","article-title":"CAR-T cells targeting activated hepatic stellate cells ameliorate liver fibrosis in mouse models","volume":"8","author":"Zhang","year":"2026","journal-title":"JHEP Rep"},{"issue":"8","key":"10.1016\/j.gastha.2026.101053_bib61","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/stmcls\/sxad029","article-title":"Liver disease and cell therapy: advances made and remaining challenges","volume":"41","author":"Khan","year":"2023","journal-title":"Stem Cells"},{"issue":"1","key":"10.1016\/j.gastha.2026.101053_bib62","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s13287-023-03494-2","article-title":"Meta-analysis on last ten years of clinical injection of bone marrow-derived and umbilical cord MSC to reverse cirrhosis or rescue patients with acute-on-chronic liver failure","volume":"14","author":"Wang","year":"2023","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"10.1016\/j.gastha.2026.101053_bib63","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/s13287-025-04535-8","article-title":"From signaling pathways to clinical trials: mesenchymal stem cells as multimodal regenerative architects in liver cirrhosis therapy","volume":"16","author":"Bozorgi","year":"2025","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"10.1016\/j.gastha.2026.101053_bib64","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1186\/s13287-025-04788-3","article-title":"Mesenchymal stem cell therapy for end-stage liver disease: adversity and opportunity","volume":"16","author":"Li","year":"2025","journal-title":"Stem Cell Res Ther"},{"issue":"10","key":"10.1016\/j.gastha.2026.101053_bib65","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1182\/blood-2007-02-069716","article-title":"Immunomodulatory properties of mesenchymal stromal cells","volume":"110","author":"Nauta","year":"2007","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.gastha.2026.101053_bib66","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.scr.2013.08.011","article-title":"Transplantation of mesenchymal stem cells for the treatment of liver diseases, is there enough evidence?","volume":"11","author":"Meier","year":"2013","journal-title":"Stem Cell Res"},{"issue":"2","key":"10.1016\/j.gastha.2026.101053_bib67","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1136\/gut.2006.111617","article-title":"Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential","volume":"57","author":"di Bonzo","year":"2008","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.gastha.2026.101053_bib68","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13287-022-02754-x","article-title":"Mesenchymal stem cells protect against acetaminophen hepatotoxicity by secreting regenerative cytokine hepatocyte growth factor","volume":"13","author":"Wang","year":"2022","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"10.1016\/j.gastha.2026.101053_bib69","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3350\/cmh.2015.21.2.141","article-title":"Inhibition of hepatic stellate cells by bone marrow-derived mesenchymal stem cells in hepatic fibrosis","volume":"21","author":"Jang","year":"2015","journal-title":"Clin Mol Hepatol"},{"issue":"1","key":"10.1016\/j.gastha.2026.101053_bib70","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13287-017-0575-5","article-title":"Human liver mesenchymal stem\/progenitor cells inhibit hepatic stellate cell activation: in vitro and in vivo evaluation","volume":"8","author":"Najimi","year":"2017","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.gastha.2026.101053_bib71","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1239143","article-title":"NADPH oxidase signaling pathway mediates mesenchymal stem cell-induced inhibition of hepatic stellate cell activation","volume":"2018","author":"Qiao","year":"2018","journal-title":"Stem Cells Int"},{"issue":"4","key":"10.1016\/j.gastha.2026.101053_bib72","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1097\/HEP.0000000000000831","article-title":"Mesenchymal stem cells alleviate mouse liver fibrosis by inhibiting pathogenic function of intrahepatic B cells","volume":"81","author":"Feng","year":"2025","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.gastha.2026.101053_bib73","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1002\/hep.20452","article-title":"Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice","volume":"40","author":"Sakaida","year":"2004","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.gastha.2026.101053_bib74","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1186\/s13287-025-04812-6","article-title":"Human umbilical cord mesenchymal stem cells attenuate liver fibrosis in mice and inhibit hepatic stellate cell activation by secreting soluble factors","volume":"16","author":"Zhou","year":"2025","journal-title":"Stem Cell Res Ther"},{"issue":"10","key":"10.1016\/j.gastha.2026.101053_bib75","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3748\/wjg.v18.i10.1048","article-title":"Intravenous injection of mesenchymal stem cells is effective in treating liver fibrosis","volume":"18","author":"Zhao","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.gastha.2026.101053_bib76","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13287-018-0816-2","article-title":"A pooled analysis of mesenchymal stem cell-based therapy for liver disease","volume":"9","author":"Zhao","year":"2018","journal-title":"Stem Cell Res Ther"},{"issue":"7","key":"10.1016\/j.gastha.2026.101053_bib77","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jcyt.2025.03.505","article-title":"Overcoming challenges in MSC-sEV therapeutics: insights and advances after a decade of research","volume":"27","author":"Giebel","year":"2025","journal-title":"Cytotherapy"},{"issue":"3","key":"10.1016\/j.gastha.2026.101053_bib78","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jcyt.2018.10.014","article-title":"Mesenchymal stromal cell therapy: progress in manufacturing and assessments of potency","volume":"21","author":"Robb","year":"2019","journal-title":"Cytotherapy"},{"issue":"1","key":"10.1016\/j.gastha.2026.101053_bib79","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s13287-023-03476-4","article-title":"Enhancing mesenchymal stem cell survival and homing capability to improve cell engraftment efficacy for liver diseases","volume":"14","author":"Yu","year":"2023","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.gastha.2026.101053_bib80","doi-asserted-by":"crossref","first-page":"27066","DOI":"10.3402\/jev.v4.27066","article-title":"Biological properties of extracellular vesicles and their physiological functions","volume":"4","author":"Y\u00e1\u00f1ez-M\u00f3","year":"2015","journal-title":"J Extracell Vesicles"},{"issue":"7","key":"10.1016\/j.gastha.2026.101053_bib81","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/s41419-022-05034-x","article-title":"Mesenchymal stem cell-derived extracellular vesicles for immunomodulation and regeneration: a next generation therapeutic tool?","volume":"13","author":"Kou","year":"2022","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.gastha.2026.101053_bib82","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1186\/s13287-025-04747-y","article-title":"Mesenchymal stem cell-derived exosomes as cell-free therapeutics: mechanistic insights and engineering strategies for liver disease treatment","volume":"16","author":"Yu","year":"2025","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"10.1016\/j.gastha.2026.101053_bib83","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/hep.32129","article-title":"Extracellular vesicles derived from mesenchymal stem\/stromal cells: the regenerative impact in liver diseases","volume":"75","author":"Psaraki","year":"2022","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.gastha.2026.101053_bib84","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1186\/s12967-024-05282-9","article-title":"Mesenchymal stromal cell-derived extracellular vesicles therapy openings new translational challenges in immunomodulating acute liver inflammation","volume":"22","author":"Sitbon","year":"2024","journal-title":"J Transl Med"},{"issue":"5","key":"10.1016\/j.gastha.2026.101053_bib85","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jcyt.2021.01.001","article-title":"Critical considerations for the development of potency tests for therapeutic applications of mesenchymal stromal cell-derived small extracellular vesicles","volume":"23","author":"Gimona","year":"2021","journal-title":"Cytotherapy"},{"issue":"4","key":"10.1016\/j.gastha.2026.101053_bib86","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ni1178","article-title":"Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self","volume":"6","author":"Sakaguchi","year":"2005","journal-title":"Nat Immunol"},{"key":"10.1016\/j.gastha.2026.101053_bib87","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fimmu.2019.00043","article-title":"Past, present, and future of regulatory T cell therapy in transplantation and autoimmunity","volume":"10","author":"Romano","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.gastha.2026.101053_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1166135","article-title":"Opportunities for Treg cell therapy for the treatment of human disease","volume":"14","author":"Bluestone","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.gastha.2026.101053_bib89","article-title":"The alterations in and the role of the Th17\/Treg balance in metabolic diseases","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.gastha.2026.101053_bib90","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.584048","article-title":"Foxp3+ regulatory T cells inhibit CCl4-induced liver inflammation and fibrosis by regulating tissue cellular immunity","volume":"11","author":"Ikeno","year":"2020","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.gastha.2026.101053_bib91","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.cmet.2015.03.005","article-title":"Antigen- and cytokine-driven accumulation of regulatory T cells in visceral adipose tissue of lean mice","volume":"21","author":"Kolodin","year":"2015","journal-title":"Cell Metab"},{"issue":"8","key":"10.1016\/j.gastha.2026.101053_bib92","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/nm.2002","article-title":"Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters","volume":"15","author":"Feuerer","year":"2009","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.gastha.2026.101053_bib93","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/ni.3085","article-title":"The transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue\u2013resident regulatory T cells","volume":"16","author":"Vasanthakumar","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.gastha.2026.101053_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2025.102131","article-title":"CD73 promotes the immunoregulatory functions of hepatic Tregs through enzymatic and nonenzymatic pathways in MASLD development","volume":"96","author":"Jin","year":"2025","journal-title":"Mol Metab"},{"issue":"5","key":"10.1016\/j.gastha.2026.101053_bib95","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/hep.21823","article-title":"A high-fat diet and regulatory T cells influence susceptibility to endotoxin-induced liver injury","volume":"46","author":"Ma","year":"2007","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.gastha.2026.101053_bib96","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3390\/cancers11091221","article-title":"Integrin-mediated TGF\u03b2 activation modulates the tumour microenvironment","volume":"11","author":"Brown","year":"2019","journal-title":"Cancers"},{"issue":"105","key":"10.1016\/j.gastha.2026.101053_bib97","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adp7193","article-title":"ATF4 drives regulatory T cell functional specification in homeostasis and obesity","volume":"10","author":"Wang","year":"2025","journal-title":"Sci Immunol"},{"issue":"2","key":"10.1016\/j.gastha.2026.101053_bib98","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jhep.2013.04.011","article-title":"Intrahepatic IL-8 producing Foxp3+CD4+ regulatory T cells and fibrogenesis in chronic hepatitis C","volume":"59","author":"Langhans","year":"2013","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.gastha.2026.101053_bib99","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.3390\/cells8111419","article-title":"TGF-\u03b2 in hepatic stellate cell activation and liver fibrogenesis\u2014updated 2019","volume":"8","author":"Dewidar","year":"2019","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.gastha.2026.101053_bib100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039307","article-title":"Significance of the balance between regulatory T (Treg) and T helper 17 (Th17) cells during hepatitis B virus related liver fibrosis","volume":"7","author":"Li","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.gastha.2026.101053_bib101","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.3389\/fimmu.2020.01711","article-title":"Adoptive cell transfer of regulatory T cells exacerbates hepatic steatosis in high-fat high-fructose diet-fed mice","volume":"11","author":"Van Herck","year":"2020","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.gastha.2026.101053_bib102","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/hep4.1807","article-title":"The detrimental role of regulatory T cells in nonalcoholic steatohepatitis","volume":"6","author":"Dywicki","year":"2022","journal-title":"Hepatol Commun"},{"issue":"10","key":"10.1016\/j.gastha.2026.101053_bib103","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013577","article-title":"Hepatic expression patterns of inflammatory and immune response genes associated with obesity and NASH in morbidly obese patients","volume":"5","author":"Bertola","year":"2010","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.gastha.2026.101053_bib104","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1111\/ajt.15700","article-title":"Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation","volume":"20","author":"S\u00e1nchez-Fueyo","year":"2020","journal-title":"Am J Transpl"},{"issue":"669","key":"10.1016\/j.gastha.2026.101053_bib105","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abo2628","article-title":"Selective decrease of donor-reactive Tregs after liver transplantation limits Treg therapy for promoting allograft tolerance in humans","volume":"14","author":"Tang","year":"2022","journal-title":"Sci Transl Med"},{"issue":"7655","key":"10.1016\/j.gastha.2026.101053_bib106","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nature22395","article-title":"Therapeutic T cell engineering","volume":"545","author":"Sadelain","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.gastha.2026.101053_bib107","article-title":"Expanding the horizon of CAR T cell therapy: from cancer treatment to autoimmune diseases and beyond","volume":"16","author":"Yang","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.gastha.2026.101053_bib108","article-title":"Anti-CD206 CAR T cell treatment restores fibrosis-induced loss of dermal white adipose tissue","author":"Park","year":"2025","journal-title":"bioRxiv"},{"issue":"7774","key":"10.1016\/j.gastha.2026.101053_bib109","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-019-1546-z","article-title":"Targeting cardiac fibrosis with engineered T cells","volume":"573","author":"Aghajanian","year":"2019","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.gastha.2026.101053_bib110","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.182050","article-title":"CAR-engineered cytolytic tregs reverse pulmonary fibrosis and remodel the fibrotic niche with limited CRS","volume":"10","author":"Jiang","year":"2025","journal-title":"JCI Insight"},{"key":"10.1016\/j.gastha.2026.101053_bib111","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1188049","article-title":"From bench to bedside: the history and progress of CAR T cell therapy","volume":"14","author":"Mitra","year":"2023","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.gastha.2026.101053_bib112","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.jaci.2024.12.1066","article-title":"Chimeric antigen receptor\u2013modified T-cell therapy: recent updates and challenges in autoimmune diseases","volume":"155","author":"Ca\u00ebl","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.gastha.2026.101053_bib113","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jconrel.2019.12.047","article-title":"Current challenges and emerging opportunities of CAR-T cell therapies","volume":"319","author":"Abreu","year":"2020","journal-title":"J Control Release"},{"issue":"1","key":"10.1016\/j.gastha.2026.101053_bib114","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1172\/JCI200522675","article-title":"Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair","volume":"115","author":"Duffield","year":"2005","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.gastha.2026.101053_bib115","doi-asserted-by":"crossref","first-page":"5288","DOI":"10.4049\/jimmunol.178.8.5288","article-title":"Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis","volume":"178","author":"Fallowfield","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.gastha.2026.101053_bib116","article-title":"TREM2+ macrophages: a key role in disease development","volume":"16","author":"Wang","year":"2025","journal-title":"Front Immunol"},{"issue":"35","key":"10.1016\/j.gastha.2026.101053_bib117","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2405746121","article-title":"Lipid-associated macrophages' promotion of fibrosis resolution during MASH regression requires TREM2","volume":"121","author":"Ganguly","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.gastha.2026.101053_bib118","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.immuni.2025.01.002","article-title":"Spatially restricted and ontogenically distinct hepatic macrophages are required for tissue repair","volume":"58","author":"De Ponti","year":"2025","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.gastha.2026.101053_bib119","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jhep.2020.02.031","article-title":"Alternatively activated macrophages promote resolution of necrosis following acute liver injury","volume":"73","author":"Starkey Lewis","year":"2020","journal-title":"J Hepatol"},{"issue":"16","key":"10.1016\/j.gastha.2026.101053_bib120","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1073\/pnas.1302168110","article-title":"Bone marrow injection stimulates hepatic ductular reactions in the absence of injury via macrophage-mediated TWEAK signaling","volume":"110","author":"Bird","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.gastha.2026.101053_bib121","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jcyt.2017.05.009","article-title":"Development, functional characterization and validation of methodology for GMP-compliant manufacture of phagocytic macrophages: a novel cellular therapeutic for liver cirrhosis","volume":"19","author":"Fraser","year":"2017","journal-title":"Cytotherapy"},{"issue":"11","key":"10.1016\/j.gastha.2026.101053_bib122","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-053190","article-title":"Study protocol: a multicentre, open-label, parallel-group, phase 2, randomised controlled trial of autologous macrophage therapy for liver cirrhosis (MATCH)","volume":"11","author":"Brennan","year":"2021","journal-title":"BMJ Open"},{"issue":"7","key":"10.1016\/j.gastha.2026.101053_bib123","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.stem.2026.04.016","article-title":"Autologous macrophage therapy decreases major clinical outcomes in patients with compensated cirrhosis: extended data froma randomized controlled phase 2 trial","volume":"33","author":"Brennan","year":"2026","journal-title":"Cell Stem Cell"}],"container-title":["Gastro Hep Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572326001743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572326001743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:00:12Z","timestamp":1791547212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772572326001743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":123,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2772572326001743"],"URL":"https:\/\/doi.org\/10.1016\/j.gastha.2026.101053","relation":{},"ISSN":["2772-5723"],"issn-type":[{"value":"2772-5723","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cell Therapy in Advanced Cirrhosis: From Preclinical Evidence to Clinical Application","name":"articletitle","label":"Article Title"},{"value":"Gastro Hep Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastha.2026.101053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Gastroenterological Association Institute.","name":"copyright","label":"Copyright"}],"article-number":"101053"}}